BMRN

BioMarin Pharmaceutical (BMRN)

BioMarin Pharmaceutical Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BMRN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	06:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/05/14	04:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/05/14	04:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/05/10	23:11	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/05/09	23:54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/05/08	21:00	PR Newswire (US)	BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/05/08	06:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/05/07	05:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/05/07	05:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/05/05	05:00	PR Newswire (US)	New Data for BioMarin's VOXZOGO® (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/04/25	05:03	PR Newswire (US)	BioMarin Reports Record Financial Results for the First Quarter 2024	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/04/10	21:00	PR Newswire (US)	BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/12	21:30	PR Newswire (US)	New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/08	08:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/08	07:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/08	07:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/07	22:30	PR Newswire (US)	BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/07	02:04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/06	06:17	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/06	04:41	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/06	02:04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/01	23:00	PR Newswire (US)	BioMarin Scheduled to Participate in March Investor Conferences	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/01	07:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/01	07:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/01	07:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/01	07:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/01	07:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/03/01	07:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/02/28	00:35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/02/27	03:34	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:BMRN	BioMarin Pharmaceutical Inc